Diet, Gut Microbiota and COVID-19

Worldwide, millions of individuals have been affected by the prevailing SARS-CoV-2. Therefore, a robust immune system remains indispensable, as an immunocompromised host status has proven to be fatal. In the absence of any specific antiviral drug/vaccine, COVID-19 related drug repurposing along with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Indian journal of microbiology 2020-12, Vol.60 (4), p.420-429
Hauptverfasser: Rishi, Praveen, Thakur, Khemraj, Vij, Shania, Rishi, Lavanya, Singh, Aagamjit, Kaur, Indu Pal, Patel, Sanjay K. S., Lee, Jung-Kul, Kalia, Vipin C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 429
container_issue 4
container_start_page 420
container_title Indian journal of microbiology
container_volume 60
creator Rishi, Praveen
Thakur, Khemraj
Vij, Shania
Rishi, Lavanya
Singh, Aagamjit
Kaur, Indu Pal
Patel, Sanjay K. S.
Lee, Jung-Kul
Kalia, Vipin C.
description Worldwide, millions of individuals have been affected by the prevailing SARS-CoV-2. Therefore, a robust immune system remains indispensable, as an immunocompromised host status has proven to be fatal. In the absence of any specific antiviral drug/vaccine, COVID-19 related drug repurposing along with various other non-pharmacological measures coupled with lockdown have been employed to combat this infection. In this context, a plant based rich fiber diet, which happens to be consumed by a majority of the Indian population, appears to be advantageous, as it replenishes the host gut microbiota with beneficial microbes thereby leading to a symbiotic association conferring various health benefits to the host including enhanced immunity. Further, implementation of the lockdown which has proven to be a good non-pharmacological measure, seems to have resulted in consumption of home cooked healthy diet, thereby enriching the beneficial microflora in the gut, which might have resulted in better prognosis of COVID-19 patients in India in comparison to that observed in the western countries.
doi_str_mv 10.1007/s12088-020-00908-0
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7521193</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2450410818</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-b96c334c2a1bd5a9a54a10edd231988a3d004c853bb5852b9b1d85bc17bc7b123</originalsourceid><addsrcrecordid>eNp9kclOwzAQhi0EYim8AAdUxIUDgRkvsX1BQi1LJVAvwNWyHbcEtQnECRJvj6FQlgOnGWm--Wf5CdlFOEYAeRKRglIZUMgANKRshWyCliyTEsVqyoHnmdIaN8hWjI8AIte5WCcbjAFSlatNsj8sQ3vUv-za_k3pm9qVdWv7tir6g_H9aJih3iZrEzuLYecz9sjdxfnt4Cq7Hl-OBmfXmeeSt5nTuWeMe2rRFcJqK7hFCEVBGWqlLCvSNl4J5pxQgjrtsFDCeZTOS4eU9cjpQvepc_NQ-FC1jZ2Zp6ac2-bV1LY0vytV-WCm9YuRgiJqlgQOPwWa-rkLsTXzMvowm9kq1F00lHOVc8aVTOjBH_Sx7poqnZcoARxBoUoUXVDpLzE2YbJcBsG8O2AWDpjkgPlwwEBq2vt5xrLl6-UJYAsgplI1Dc337H9k3wAys44I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2450410818</pqid></control><display><type>article</type><title>Diet, Gut Microbiota and COVID-19</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Rishi, Praveen ; Thakur, Khemraj ; Vij, Shania ; Rishi, Lavanya ; Singh, Aagamjit ; Kaur, Indu Pal ; Patel, Sanjay K. S. ; Lee, Jung-Kul ; Kalia, Vipin C.</creator><creatorcontrib>Rishi, Praveen ; Thakur, Khemraj ; Vij, Shania ; Rishi, Lavanya ; Singh, Aagamjit ; Kaur, Indu Pal ; Patel, Sanjay K. S. ; Lee, Jung-Kul ; Kalia, Vipin C.</creatorcontrib><description>Worldwide, millions of individuals have been affected by the prevailing SARS-CoV-2. Therefore, a robust immune system remains indispensable, as an immunocompromised host status has proven to be fatal. In the absence of any specific antiviral drug/vaccine, COVID-19 related drug repurposing along with various other non-pharmacological measures coupled with lockdown have been employed to combat this infection. In this context, a plant based rich fiber diet, which happens to be consumed by a majority of the Indian population, appears to be advantageous, as it replenishes the host gut microbiota with beneficial microbes thereby leading to a symbiotic association conferring various health benefits to the host including enhanced immunity. Further, implementation of the lockdown which has proven to be a good non-pharmacological measure, seems to have resulted in consumption of home cooked healthy diet, thereby enriching the beneficial microflora in the gut, which might have resulted in better prognosis of COVID-19 patients in India in comparison to that observed in the western countries.</description><identifier>ISSN: 0046-8991</identifier><identifier>EISSN: 0973-7715</identifier><identifier>DOI: 10.1007/s12088-020-00908-0</identifier><identifier>PMID: 33012868</identifier><language>eng</language><publisher>New Delhi: Springer India</publisher><subject>Biomedical and Life Sciences ; Coronaviruses ; COVID-19 ; Diet ; Immune system ; Intestinal microflora ; Life Sciences ; Medical Microbiology ; Microbiology ; Microbiota ; Pharmacology ; Review ; Review Article ; Severe acute respiratory syndrome coronavirus 2</subject><ispartof>Indian journal of microbiology, 2020-12, Vol.60 (4), p.420-429</ispartof><rights>Association of Microbiologists of India 2020</rights><rights>Association of Microbiologists of India 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-b96c334c2a1bd5a9a54a10edd231988a3d004c853bb5852b9b1d85bc17bc7b123</citedby><cites>FETCH-LOGICAL-c474t-b96c334c2a1bd5a9a54a10edd231988a3d004c853bb5852b9b1d85bc17bc7b123</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521193/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521193/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,41469,42538,51300,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33012868$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rishi, Praveen</creatorcontrib><creatorcontrib>Thakur, Khemraj</creatorcontrib><creatorcontrib>Vij, Shania</creatorcontrib><creatorcontrib>Rishi, Lavanya</creatorcontrib><creatorcontrib>Singh, Aagamjit</creatorcontrib><creatorcontrib>Kaur, Indu Pal</creatorcontrib><creatorcontrib>Patel, Sanjay K. S.</creatorcontrib><creatorcontrib>Lee, Jung-Kul</creatorcontrib><creatorcontrib>Kalia, Vipin C.</creatorcontrib><title>Diet, Gut Microbiota and COVID-19</title><title>Indian journal of microbiology</title><addtitle>Indian J Microbiol</addtitle><addtitle>Indian J Microbiol</addtitle><description>Worldwide, millions of individuals have been affected by the prevailing SARS-CoV-2. Therefore, a robust immune system remains indispensable, as an immunocompromised host status has proven to be fatal. In the absence of any specific antiviral drug/vaccine, COVID-19 related drug repurposing along with various other non-pharmacological measures coupled with lockdown have been employed to combat this infection. In this context, a plant based rich fiber diet, which happens to be consumed by a majority of the Indian population, appears to be advantageous, as it replenishes the host gut microbiota with beneficial microbes thereby leading to a symbiotic association conferring various health benefits to the host including enhanced immunity. Further, implementation of the lockdown which has proven to be a good non-pharmacological measure, seems to have resulted in consumption of home cooked healthy diet, thereby enriching the beneficial microflora in the gut, which might have resulted in better prognosis of COVID-19 patients in India in comparison to that observed in the western countries.</description><subject>Biomedical and Life Sciences</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Diet</subject><subject>Immune system</subject><subject>Intestinal microflora</subject><subject>Life Sciences</subject><subject>Medical Microbiology</subject><subject>Microbiology</subject><subject>Microbiota</subject><subject>Pharmacology</subject><subject>Review</subject><subject>Review Article</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><issn>0046-8991</issn><issn>0973-7715</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kclOwzAQhi0EYim8AAdUxIUDgRkvsX1BQi1LJVAvwNWyHbcEtQnECRJvj6FQlgOnGWm--Wf5CdlFOEYAeRKRglIZUMgANKRshWyCliyTEsVqyoHnmdIaN8hWjI8AIte5WCcbjAFSlatNsj8sQ3vUv-za_k3pm9qVdWv7tir6g_H9aJih3iZrEzuLYecz9sjdxfnt4Cq7Hl-OBmfXmeeSt5nTuWeMe2rRFcJqK7hFCEVBGWqlLCvSNl4J5pxQgjrtsFDCeZTOS4eU9cjpQvepc_NQ-FC1jZ2Zp6ac2-bV1LY0vytV-WCm9YuRgiJqlgQOPwWa-rkLsTXzMvowm9kq1F00lHOVc8aVTOjBH_Sx7poqnZcoARxBoUoUXVDpLzE2YbJcBsG8O2AWDpjkgPlwwEBq2vt5xrLl6-UJYAsgplI1Dc337H9k3wAys44I</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Rishi, Praveen</creator><creator>Thakur, Khemraj</creator><creator>Vij, Shania</creator><creator>Rishi, Lavanya</creator><creator>Singh, Aagamjit</creator><creator>Kaur, Indu Pal</creator><creator>Patel, Sanjay K. S.</creator><creator>Lee, Jung-Kul</creator><creator>Kalia, Vipin C.</creator><general>Springer India</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201201</creationdate><title>Diet, Gut Microbiota and COVID-19</title><author>Rishi, Praveen ; Thakur, Khemraj ; Vij, Shania ; Rishi, Lavanya ; Singh, Aagamjit ; Kaur, Indu Pal ; Patel, Sanjay K. S. ; Lee, Jung-Kul ; Kalia, Vipin C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-b96c334c2a1bd5a9a54a10edd231988a3d004c853bb5852b9b1d85bc17bc7b123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biomedical and Life Sciences</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Diet</topic><topic>Immune system</topic><topic>Intestinal microflora</topic><topic>Life Sciences</topic><topic>Medical Microbiology</topic><topic>Microbiology</topic><topic>Microbiota</topic><topic>Pharmacology</topic><topic>Review</topic><topic>Review Article</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rishi, Praveen</creatorcontrib><creatorcontrib>Thakur, Khemraj</creatorcontrib><creatorcontrib>Vij, Shania</creatorcontrib><creatorcontrib>Rishi, Lavanya</creatorcontrib><creatorcontrib>Singh, Aagamjit</creatorcontrib><creatorcontrib>Kaur, Indu Pal</creatorcontrib><creatorcontrib>Patel, Sanjay K. S.</creatorcontrib><creatorcontrib>Lee, Jung-Kul</creatorcontrib><creatorcontrib>Kalia, Vipin C.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rishi, Praveen</au><au>Thakur, Khemraj</au><au>Vij, Shania</au><au>Rishi, Lavanya</au><au>Singh, Aagamjit</au><au>Kaur, Indu Pal</au><au>Patel, Sanjay K. S.</au><au>Lee, Jung-Kul</au><au>Kalia, Vipin C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diet, Gut Microbiota and COVID-19</atitle><jtitle>Indian journal of microbiology</jtitle><stitle>Indian J Microbiol</stitle><addtitle>Indian J Microbiol</addtitle><date>2020-12-01</date><risdate>2020</risdate><volume>60</volume><issue>4</issue><spage>420</spage><epage>429</epage><pages>420-429</pages><issn>0046-8991</issn><eissn>0973-7715</eissn><abstract>Worldwide, millions of individuals have been affected by the prevailing SARS-CoV-2. Therefore, a robust immune system remains indispensable, as an immunocompromised host status has proven to be fatal. In the absence of any specific antiviral drug/vaccine, COVID-19 related drug repurposing along with various other non-pharmacological measures coupled with lockdown have been employed to combat this infection. In this context, a plant based rich fiber diet, which happens to be consumed by a majority of the Indian population, appears to be advantageous, as it replenishes the host gut microbiota with beneficial microbes thereby leading to a symbiotic association conferring various health benefits to the host including enhanced immunity. Further, implementation of the lockdown which has proven to be a good non-pharmacological measure, seems to have resulted in consumption of home cooked healthy diet, thereby enriching the beneficial microflora in the gut, which might have resulted in better prognosis of COVID-19 patients in India in comparison to that observed in the western countries.</abstract><cop>New Delhi</cop><pub>Springer India</pub><pmid>33012868</pmid><doi>10.1007/s12088-020-00908-0</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0046-8991
ispartof Indian journal of microbiology, 2020-12, Vol.60 (4), p.420-429
issn 0046-8991
0973-7715
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7521193
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; SpringerLink Journals - AutoHoldings
subjects Biomedical and Life Sciences
Coronaviruses
COVID-19
Diet
Immune system
Intestinal microflora
Life Sciences
Medical Microbiology
Microbiology
Microbiota
Pharmacology
Review
Review Article
Severe acute respiratory syndrome coronavirus 2
title Diet, Gut Microbiota and COVID-19
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T04%3A32%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diet,%20Gut%20Microbiota%20and%20COVID-19&rft.jtitle=Indian%20journal%20of%20microbiology&rft.au=Rishi,%20Praveen&rft.date=2020-12-01&rft.volume=60&rft.issue=4&rft.spage=420&rft.epage=429&rft.pages=420-429&rft.issn=0046-8991&rft.eissn=0973-7715&rft_id=info:doi/10.1007/s12088-020-00908-0&rft_dat=%3Cproquest_pubme%3E2450410818%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2450410818&rft_id=info:pmid/33012868&rfr_iscdi=true